Ken Wojcikowski

901 total citations
17 papers, 703 citations indexed

About

Ken Wojcikowski is a scholar working on Complementary and alternative medicine, Radiology, Nuclear Medicine and Imaging and Pharmacology. According to data from OpenAlex, Ken Wojcikowski has authored 17 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Complementary and alternative medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Pharmacology. Recurrent topics in Ken Wojcikowski's work include Nephrotoxicity and Medicinal Plants (5 papers), Complementary and Alternative Medicine Studies (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Ken Wojcikowski is often cited by papers focused on Nephrotoxicity and Medicinal Plants (5 papers), Complementary and Alternative Medicine Studies (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Ken Wojcikowski collaborates with scholars based in Australia, United States and Pakistan. Ken Wojcikowski's co-authors include Glenda C. Gobé, David W. Johnson, Hans Wohlmuth, Arham Shabbir, Muhammad Shahzad, Lesley Stevenson, David N. Leach, Stephen P Myers, Lyndon Brooks and Margaret Rolfe and has published in prestigious journals such as Journal of Ethnopharmacology, Food and Chemical Toxicology and Phytotherapy Research.

In The Last Decade

Ken Wojcikowski

17 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Wojcikowski Australia 12 200 195 157 143 106 17 703
Ihab T. Abdel‐Raheem Egypt 12 70 0.3× 138 0.7× 180 1.1× 79 0.6× 141 1.3× 23 755
Marwa M. Khalaf Egypt 14 73 0.4× 235 1.2× 127 0.8× 67 0.5× 79 0.7× 42 714
Mohammad M. Al-Harbi Saudi Arabia 17 335 1.7× 192 1.0× 155 1.0× 83 0.6× 48 0.5× 26 941
Mohammad Jafar Zamani Iran 13 71 0.4× 197 1.0× 103 0.7× 123 0.9× 102 1.0× 15 793
Jung‐Chun Liao Taiwan 12 129 0.6× 237 1.2× 373 2.4× 162 1.1× 102 1.0× 17 784
De Jin China 15 198 1.0× 347 1.8× 131 0.8× 48 0.3× 89 0.8× 52 835
Chuang‐Ye Hong Taiwan 17 169 0.8× 228 1.2× 131 0.8× 75 0.5× 133 1.3× 31 716
Xiaopeng Chen China 12 123 0.6× 227 1.2× 128 0.8× 71 0.5× 45 0.4× 38 484
Carla F.S. Guazelli Brazil 10 59 0.3× 196 1.0× 144 0.9× 72 0.5× 80 0.8× 13 636
S.A. Mengi India 13 255 1.3× 209 1.1× 103 0.7× 185 1.3× 102 1.0× 22 868

Countries citing papers authored by Ken Wojcikowski

Since Specialization
Citations

This map shows the geographic impact of Ken Wojcikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Wojcikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Wojcikowski more than expected).

Fields of papers citing papers by Ken Wojcikowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Wojcikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Wojcikowski. The network helps show where Ken Wojcikowski may publish in the future.

Co-authorship network of co-authors of Ken Wojcikowski

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Wojcikowski. A scholar is included among the top collaborators of Ken Wojcikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Wojcikowski. Ken Wojcikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wojcikowski, Ken, Vanessa Vigar, & Christopher J. Oliver. (2020). New Concepts of Chronic Pain and the Potential Role of Complementary Therapies.. PubMed. 26(S1). 18–31. 8 indexed citations
2.
Gobé, Glenda C. & Ken Wojcikowski. (2019). Nontraditional (non-Western pharmaceutical) treatments for chronic kidney disease. Clinical Nephrology. 93(1). 49–54. 5 indexed citations
3.
Shahzad, Muhammad, Arham Shabbir, Ken Wojcikowski, Hans Wohlmuth, & Glenda C. Gobé. (2016). The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease. Current Drug Targets. 17(12). 1331–1340. 149 indexed citations
4.
Shahzad, Muhammad, David M. Small, Christudas Morais, et al.. (2015). Protection against oxidative stress-induced apoptosis in kidney epithelium by Angelica and Astragalus. Journal of Ethnopharmacology. 179. 412–419. 25 indexed citations
5.
Wojcikowski, Ken, et al.. (2013). Immediate detailed feedback to test-enhanced learning: An effective online educational tool. Medical Teacher. 35(11). 915–919. 31 indexed citations
6.
Wojcikowski, Ken & Sonya Brownie. (2013). Generic reflective feedback: An effective approach to developing clinical reasoning skills. Journal of Computer Assisted Learning. 29(4). 371–382. 2 indexed citations
7.
Wojcikowski, Ken & Glenda C. Gobé. (2013). Animal Studies on Medicinal Herbs: Predictability, Dose Conversion and Potential Value. Phytotherapy Research. 28(1). 22–27. 99 indexed citations
9.
Wojcikowski, Ken, Hans Wohlmuth, David W. Johnson, & Glenda C. Gobé. (2009). Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathy. Phytotherapy Research. 24(6). 875–884. 16 indexed citations
10.
O’Reilly, Meg & Ken Wojcikowski. (2008). Clinical diagnosis online. ASCILITE Publications. 701–710. 1 indexed citations
11.
Wojcikowski, Ken, Hans Wohlmuth, David W. Johnson, Margaret Rolfe, & Glenda C. Gobé. (2008). An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects. Nephrology. 14(1). 70–79. 29 indexed citations
12.
Wojcikowski, Ken, Hans Wohlmuth, David W. Johnson, & Glenda C. Gobé. (2008). Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways. Food and Chemical Toxicology. 46(9). 3122–3131. 31 indexed citations
13.
Wojcikowski, Ken, Lesley Stevenson, David N. Leach, Hans Wohlmuth, & Glenda C. Gobé. (2007). Antioxidant Capacity of 55 Medicinal Herbs Traditionally Used to Treat The Urinary System: A Comparison Using A Sequential Three-Solvent Extraction Process. The Journal of Alternative and Complementary Medicine. 13(1). 103–110. 89 indexed citations
14.
Wojcikowski, Ken, Stephen P Myers, & Lyndon Brooks. (2007). Effects of garlic oil on platelet aggregation: A double blind placebo controlled crossover study. Platelets. 18(1). 29–34. 26 indexed citations
15.
Wojcikowski, Ken, David W. Johnson, & Glenda C. Gobé. (2006). Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. Journal of Laboratory and Clinical Medicine. 147(4). 160–166. 90 indexed citations
16.
Wojcikowski, Ken, David W. Johnson, & Glenda C. Gobé. (2004). Medicinal herbal extracts – renal friend or foe? Part one: The toxicities of medicinal herbs. Nephrology. 9(5). 313–318. 67 indexed citations
17.
Wojcikowski, Ken, David W. Johnson, & Glenda C. Gobé. (2004). Medicinal herbal extracts – renal friend or foe? Part two: Herbal extracts with potential renal benefits. Nephrology. 9(6). 400–405. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026